Literature DB >> 6440032

The effect of imipramine and desipramine on mixed function oxidase in rats.

W Daniel, J Friebertshäuser, C Steffen.   

Abstract

The effects of imipramine and desipramine on hepatic mixed function oxidase were measured in male Wistar rats. Both antidepressants increased hepatic cytochrome P-450 when given b.i.d. for 7 or 14 days. In vitro demethylation of imipramine was rather depressed than increased. 14CO2 exhalation from [N-methyl-14C] benzphetamine was increased by pretreatment with the antidepressants as well as with phenobarbital, but imipramine had no influence on the exhalation of the label from [6-methoxy-14C]- or [7-methoxy-14C]-scoparone. No difference was observed between treatment with imipramine or desipramine. It is concluded that changes of the demethylation rate of imipramine are not responsible for its delayed elimination observed after chronic treatment (Daniel et al. 1981).

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6440032     DOI: 10.1007/bf00496111

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  17 in total

1.  THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE.

Authors:  T OMURA; R SATO
Journal:  J Biol Chem       Date:  1964-07       Impact factor: 5.157

2.  Perazine, chlorpromazine and imipramine as inducers of microsomal drug metabolism.

Authors:  U Breyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

3.  Microsomal oxidase. IV. Properties of a mixed-function amine oxidase isolated from pig liver microsomes.

Authors:  D M Ziegler; C H Mitchell
Journal:  Arch Biochem Biophys       Date:  1972-05       Impact factor: 4.013

4.  Metabolism of propranolol by rat liver microsomes and its inhibition by phenothiazine and tricyclic antidepressant drugs.

Authors:  D G Shand; J A Oates
Journal:  Biochem Pharmacol       Date:  1971-07       Impact factor: 5.858

5.  The total fate of a drug: kinetics of distribution, excretion, and formation of 14 metabolites in rats treated with imipramine.

Authors:  M H Bickel; H J Weder
Journal:  Arch Int Pharmacodyn Ther       Date:  1968-06

6.  Studies on the demethylation, hydroxylation and N-oxidation of imipramine in rat liver.

Authors:  K Nakazawa
Journal:  Biochem Pharmacol       Date:  1970-04       Impact factor: 5.858

7.  Inhibitory mechanism of imipramine on barbiturate metabolism in rat liver.

Authors:  K Kakemi; H Sezaki; R Konishi; T Kimura
Journal:  Chem Pharm Bull (Tokyo)       Date:  1971-07       Impact factor: 1.645

8.  [A fluorometic test for microsomal monooxygenase activity in the rat liver with scoparone as substrate (author's transl)].

Authors:  D Müller-Enoch; H Thomas; H Ockenfels
Journal:  Z Naturforsch C Biosci       Date:  1979 May-Jun

9.  Cerebral pharmacokinetics of imipramine in rats after single and multiple dosages.

Authors:  W Daniel; A Adamus; M Melzacka; J Szymura; J Vetulani
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-11       Impact factor: 3.000

10.  SPECIES DIFFERENCES IN THE METABOLISM OF IMIPRAMINE AND DESMETHYLIMIPRAMINE (DMI).

Authors:  J V DINGELL; F SULSER; J R GILLETTE
Journal:  J Pharmacol Exp Ther       Date:  1964-01       Impact factor: 4.030

View more
  4 in total

1.  Alteration of cytochrome P-450 by prolonged administration of imipramine and/or lithium to rats.

Authors:  W Daniel; K J Netter
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-08       Impact factor: 3.000

2.  Metabolic interaction between imipramine and carbamazepine in vivo and in vitro in rats.

Authors:  W Daniel; K J Netter
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-01       Impact factor: 3.000

3.  Pharmacokinetic interaction between carbamazepine and neuroleptics after combined prolonged treatment in rats.

Authors:  W Daniel; L Janczar; L Danek; W Legrum; K J Netter
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-05       Impact factor: 3.000

4.  Enhanced oxidative phosphorylation in rat liver mitochondria following prolonged in vivo treatment with imipramine.

Authors:  S S Katyare; R R Rajan
Journal:  Br J Pharmacol       Date:  1988-11       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.